Abstract
This FAQ is based on webinars and NITAG trainings and include:
- What is the key role of NITAGs in health economic evaluation?
- What if the NITAG is from a donor-dependent country?
- Do we need health economic evaluations for every intervention?
- With very limited resources and while still struggling with basic vaccination of young children, how can we justify expanding to adult and other groups?
- What is the difference between opportunity cost and allocation?
- What is the role of health economic evaluation in pandemic situation?
Last updated on March 17th 2025.
